Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the New InsiGHTS Trial.
- DOI
- 10.1210/clinem/dgag436
- Published
- 2026 Oct 26
- Container
- The Journal of clinical endocrinology and metabolism
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1210/clinem/dgag436,
title = {Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the New InsiGHTS Trial.},
author = {Davis SM and Abuzzahab MJ and Tryggestad JB and Fechner PY and Gutmark-Little I and Woods K and Fadoju D and Stafford D and Nwosu BU and Iklé JM and Abdelrahman SG and Zhen X and Mao M and Komirenko AS and Shu AD and Klein KO and New InsiGHTS Investigator Group and the},
year = {2026},
journal = {The Journal of clinical endocrinology and metabolism},
doi = {10.1210/clinem/dgag436},
url = {https://doi.org/10.1210/clinem/dgag436}
}RIS
TY - JOUR TI - Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the New InsiGHTS Trial. AU - Davis SM AU - Abuzzahab MJ AU - Tryggestad JB AU - Fechner PY AU - Gutmark-Little I AU - Woods K AU - Fadoju D AU - Stafford D AU - Nwosu BU AU - Iklé JM AU - Abdelrahman SG AU - Zhen X AU - Mao M AU - Komirenko AS AU - Shu AD AU - Klein KO AU - New InsiGHTS Investigator Group AU - the PY - 2026 JO - The Journal of clinical endocrinology and metabolism DO - 10.1210/clinem/dgag436 UR - https://doi.org/10.1210/clinem/dgag436 ER -
APA
SM, D., MJ, A., JB, T., PY, F., I, G., K, W., D, F., D, S., BU, N., JM, I., SG, A., X, Z., M, M., AS, K., AD, S., KO, K., Group, N. I. I., & the (2026). Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the New InsiGHTS Trial.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag436
Source records
- pubmed · retrieved 2026-11-10T11:08:03.732Z